Akroswiss AG
Innovative Nasal Treatments in CNS
Akroswiss aims to develop, manufacture, and commercialize innovative nasal treatments in CNS. We are pursuing EMA marketing authorization for our two indications in Anxiolytics and Epileptics.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
No Awards
Akroswiss AG
Innovative Nasal Treatments in CNS
Website:
www.akroswiss.ch
Headquarter:
Zug
Foundation Date:
December 2006
Technology:
- Biotech
Sectors:
- Biotech